M Kathleen Behrens Sarepta Therapeutics, Inc. (SRPT) insider trading activity

M Kathleen Behrens is of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 191,093 shares of SRPT, which is worth approximately $21.8 Million. The most recent transaction as insider was on Sep 04, 2024, when has been sold 746 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 191K

0.39% 3M change

9.2% 12M change

Total Value Held $21.8 Million

M KATHLEEN BEHRENS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 04 2024	SELL Bona fide gift	-	746 Reduced 0.39%	191,093 Common Stock
Jul 03 2024	BUY Exercise of conversion of derivative security	$208,500 $13.9 p/Share	15,000 Added 7.25%	191,839 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	1,846 Added 1.03%	176,839 Common Stock
Nov 03 2023	BUY Exercise of conversion of derivative security	$435,450 $29.03 p/Share	15,000 Added 7.9%	174,993 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	1,523 Added 0.94%	159,993 Common Stock
Dec 19 2022	BUY Exercise of conversion of derivative security	$698,400 $34.92 p/Share	20,000 Added 11.21%	158,470 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	-	2,953 Added 2.09%	138,470 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	$50,400 $10.08 p/Share	5,000 Added 3.56%	135,517 Common Stock
Mar 10 2021	SELL Open market or private sale	$428,800 $85.76 p/Share	5,000 Reduced 3.69%	130,517 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	$211,500 $42.3 p/Share	5,000 Added 3.56%	135,517 Common Stock
Mar 03 2021	BUY Grant, award, or other acquisition	-	2,726 Added 2.05%	130,517 Common Stock

Also insider at

IGMS

IGM Biosciences, Inc. Healthcare

MDXG

MIMEDX GROUP, INC. Healthcare

Director

MKB